Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa Ward

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|July 16, 2025
Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1Alyssa Ward, Luis J Baeza-Ballesteros, Ryan J Schuck, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|June 25, 2021
Posttraumatic stress in NICU mothers: modeling the roles of childhood trauma and infant healthAllison Baylor Williams, Karen D Hendricks-Muñoz, Anna Beth Parlier-Ahmad, et al.
Chemical & Pharmaceutical Bulletin|March 11, 2026
Screening the Human Proteome for Peptides Targeting the Acidic Environment of Tumor TissuesKenta Tanito, Shoki Munekawa, Chie Kikutake, et al.
Journal of Consulting and Clinical Psychology|August 28, 2013
Long-term outcomes for the Child STEPs randomized effectiveness trial: a comparison of modular and standard treatment designs with usual careBruce F Chorpita, John R Weisz, Eric L Daleiden, et al.
Research Square|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|January 25, 2021
Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|August 3, 2021
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCsMonique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Translational Medicine|August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|July 16, 2025
Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1Alyssa Ward, Luis J Baeza-Ballesteros, Ryan J Schuck, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|June 25, 2021
Posttraumatic stress in NICU mothers: modeling the roles of childhood trauma and infant healthAllison Baylor Williams, Karen D Hendricks-Muñoz, Anna Beth Parlier-Ahmad, et al.
Chemical & Pharmaceutical Bulletin|March 11, 2026
Screening the Human Proteome for Peptides Targeting the Acidic Environment of Tumor TissuesKenta Tanito, Shoki Munekawa, Chie Kikutake, et al.
Journal of Consulting and Clinical Psychology|August 28, 2013
Long-term outcomes for the Child STEPs randomized effectiveness trial: a comparison of modular and standard treatment designs with usual careBruce F Chorpita, John R Weisz, Eric L Daleiden, et al.
Research Square|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|January 25, 2021
Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Nature|August 3, 2021
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCsMonique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Translational Medicine|August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Pageof 3